Abstracts of distinction

ATU-7 Incident acute kidney injury has a worse prognosis than baseline in severe alcoholic hepatitis

Pub Date : 2021-11-01 DOI: 10.1136/gutjnl-2021-bsg.44 Luke D. Tyson, Professor Mark Thursz, E. Forrest, M. Allison, N. Vergis, S. Atkinson

ATU-3 Risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications: Reassuring insights from PREPARE-IBD

Pub Date : 2021-11-01 DOI: 10.1136/gutjnl-2021-bsg.41 C. Lamb, S. Sebastian, A. Kent, Jonathan P. Segal, H. Gonzalez, M. Brookes, S. Mehta, S. Subramanian, N. Bhala, L. Hicks, T. Conley, K. Patel, G. Walker, N. Kennedy

ATU-2 A multi-centre study of Infliximab treatment for corticosteroid-refractory Checkpoint Inhibitor Induced enterocolitis

Pub Date : 2021-11-01 DOI: 10.1136/gutjnl-2021-bsg.40 J. Alexander, H. Ibraheim, Bhavisha P. Sheth, D. Pinato, J. Teare, A. Speight, S. Papa, A. Sharma, Shanthini M. Crusz, N. Powell